Spruce Biosciences, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-11.8M | $-11.8M | — | $1.1M |
| Jun 2022 | $-9.5M | $-9.5M | — | $905.0K |
| Sep 2022 | $-8.6M | $-8.6M | — | $783.0K |
| Dec 2022 | $-11.7M | $-11.7M | — | $802.0K |
| Mar 2023 | $-11.8M | $-11.8M | — | $1.1M |
| Jun 2023 | $2.0M | $2.0M | — | $1.2M |
| Sep 2023 | $-12.3M | $-12.3M | — | $1.1M |
| Dec 2023 | $-11.2M | $-11.2M | — | $1.2M |
| Mar 2024 | $-15.0M | $-15.0M | — | $1.6M |
| Jun 2024 | $-11.1M | $-11.1M | — | $1.7M |
| Sep 2024 | $-9.2M | $-9.2M | — | $1.1M |
| Dec 2024 | $-20.7M | $-20.7M | — | $961.0K |
| Mar 2025 | $-12.7M | $-12.7M | $0 | $544.0K |
| Jun 2025 | $-8.8M | $-8.8M | $0 | $-77.0K |
| Sep 2025 | $-5.3M | $-5.3M | — | $415.0K |
| Dec 2025 | $-6.5M | $-6.5M | — | $1.7M |
| Mar 2026 | $-8.7M | $-8.7M | $10.0K | $689.0K |
| Jun 2026 | $-22.1M | $-22.3M | $135.0K | $871.0K |